|Bid||32.50 x 900|
|Ask||36.64 x 900|
|Day's range||35.68 - 36.40|
|52-week range||30.65 - 50.79|
|Beta (5Y monthly)||1.14|
|PE ratio (TTM)||18.04|
|Earnings date||02 Nov 2021 - 08 Nov 2021|
|Forward dividend & yield||1.76 (4.94%)|
|Ex-dividend date||19 Aug 2021|
|1y target est||60.00|
Buying a low-cost index fund will get you the average market return. But if you invest in individual stocks, some are...
Alpharetta, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Scapa Healthcare, an SWM International (NYSE: SWM) business and the trusted strategic partner for the world’s leading companies in advanced wound care, consumer wellness, and medical device and fixation, and Synedgen Inc., a biotechnology company using glycochemistry to develop drugs that enhance and mimic the innate immune system, announced today that they have signed an exclusive worldwide licensing agreement for two novel innovative wound care tre
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...